Authors: Ronchese, F Hermans, IF

Citation: F. Ronchese et If. Hermans, Killing of dendritic cells: A life cut short or a purposeful death?, J EXP MED, 194(5), 2001, pp. F23-F26

Authors: Ritchie, DS Hermans, IF Lumsden, JM Scanga, CB Roberts, JM Yang, JP Kemp, RA Ronchese, F

Citation: Ds. Ritchie et al., Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo, J IMMUNOL M, 246(1-2), 2000, pp. 109-117

Authors: Rawson, P Hermans, IF Huck, SP Roberts, JM Pircher, H Ronchese, F

Citation: P. Rawson et al., Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells, CANCER RES, 60(16), 2000, pp. 4493-4498

Authors: Hermans, IF Ritchie, DS Daish, A Yang, JP Kehry, MR Ronchese, F

Citation: If. Hermans et al., Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation, J IMMUNOL, 163(1), 1999, pp. 77-81

Authors: McCoy, KD Hermans, IF Fraser, JH Le Gros, G Ronchese, F

Citation: Kd. Mccoy et al., Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity CD8(+) T cells independently of CD4(+) T cell help, J EXP MED, 189(7), 1999, pp. 1157-1162